LD-2 disclosure · 3rd Quarter - Report
GLENMARK PHARMACEUTICALS USA
Expenses$277Kself-filed spend
Client
- Description
- Pharmaceutical manufacturing
- Location
- New Jersey · United States of America
Registrant
- Description
- Pharmaceutical manufacturing
- Location
- Mahwah, New Jersey, United States of America
Lobbying activities
2 issuesMedicare/Medicaid
Medicaid generics penalty
LobbyistsGRANT ERDEL
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
Generic drug exclusivity; BLOCKING Act; prescription drug manufacturing.
LobbyistsGRANT ERDEL
TargetedSENATE · HOUSE OF REPRESENTATIVES